Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of MPL-Adjuvanted Hepatitis B Vaccine vs Engerix-B
NCT00698087Phase 3Completed
- Sponsor
- GSK
- Start
- Jan 1995
- Primary completion
- Feb 1996
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of hepatitis b vaccine recombinant in hepatitis B (HBV) (3 arms), sponsored by GSK. Primary endpoints: Anti-HBs antibody concentrations at Month 13, Occurrence of local and general solicited symptoms and 1 more. Started Jan 1995; status: completed.
02
Drugs
hepatitis b vaccine recombinant
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00698087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00698087.